ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Amgen Takes Its Case for Aranesp To Lawmakers, Patients, Physicians

January 31, 2003

Capitol Hill: With money tight, support for 2015 goal is symbolic.

October 14, 2005

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds.

January 13, 2006

Senate Subcommittee Approves 3.5 Percent Increase for NIH.

June 29, 2007

AACI Recommends Cancer Control Guideline Changes

February 9, 1979